The science was world-class. The challenge was making sure the world knew it. I led enterprise messaging and content strategy to elevate ASN's High Impact Clinical Trials program into a recognized global platform — one credible enough for leading researchers to choose and compelling enough to drive broad media interest. That meant building a narrative architecture that could translate rigorous clinical data into clear, resonant stories for clinicians, press, and industry stakeholders simultaneously, across a 12,000-person event and beyond.
